Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,347,363 papers from all fields of science
Search
Sign In
Create Free Account
Cellular Assay
In vitro experiments conducted with intact, living cells.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Design and synthesis of alkyl substituted pyridino[2,3-D]pyrimidine compounds as PI3Kα/mTOR dual inhibitors with improved pharmacokinetic properties and potent in vivo antitumor activity.
Yinyin Liu
,
Q. Xia
,
Lei Fang
Bioorganic & Medicinal Chemistry
2018
Corpus ID: 49432694
2014
2014
Capillary electrophoresis-based assessment of nanobody affinity and purity.
R. Haselberg
,
S. Oliveira
,
R. van der Meel
,
G. Somsen
,
G. D. de Jong
Analytica Chimica Acta
2014
Corpus ID: 25841444
2010
2010
BacMam-Enabled LanthaScreen® Cellular Assays for PI3K/Akt Pathway Compound Profiling in Disease-Relevant Cell Backgrounds
C. Carlson
,
Michael J Mashock
,
K. Bi
Journal of biomolecular screening
2010
Corpus ID: 11670734
The authors recently reported the development and application of multiple LanthaScreen® cellular assays to interrogate specific…
Expand
2006
2006
A cellular assay for measuring the modulation of glucose production in H4IIE cells.
Anne-Marie de Raemy-Schenk
,
Solenne Troublé
,
+5 authors
K. Yeow
Assay and drug development technologies
2006
Corpus ID: 22513474
Type II diabetes and its associated complications are a major health concern of the developed world. One of the hallmarks of…
Expand
Highly Cited
2005
Highly Cited
2005
Methyl scanning: total synthesis of demethylasterriquinone B1 and derivatives for identification of sites of interaction with and isolation of its receptor(s).
M. Pirrung
,
Yufa Liu
,
+6 authors
N. Webster
Journal of the American Chemical Society
2005
Corpus ID: 36102740
The principle of methyl scanning is proposed for determination of the sites of interaction between biologically active small…
Expand
Highly Cited
2004
Highly Cited
2004
Synthesis of Hydroxy Derivatives of Highly Potent Non-steroidal CYP 17 Inhibitors as Potential Metabolites and Evaluation of their Activity by a Non Cellular Assay using Recombinant Human Enzyme
Tilman U. Hutschenreuter
,
P. B. Ehmer
,
R. Hartmann
Journal of Enzyme Inhibition and Medicinal…
2004
Corpus ID: 22012429
Inhibition of CYP 17 is a promising strategy for the treatment of prostate cancer. Recently two non-steroidal compounds with high…
Expand
2002
2002
A novel N-methyl-D-aspartate receptor open channel blocker with in vivo neuroprotectant activity.
R. Planells-Cases
,
C. Montoliu
,
+8 authors
A. Ferrer-Montiel
Journal of Pharmacology and Experimental…
2002
Corpus ID: 15872465
Excitotoxicity has been implicated in the etiology of ischemic stroke, chronic neurodegenerative disorders, and very recently, in…
Expand
1993
1993
Establishment of a cellular assay system for G protein-linked receptors: coupling of human NK2 and 5-HT2 receptors to phospholipase C activates a luciferase reporter gene.
U. Weyer
,
R. Schäfer
,
+4 authors
C. Stratowa
Receptors and Channels
1993
Corpus ID: 23980608
A functional cellular assay system was developed for the detection of substances modulating the activity of G protein-coupled…
Expand
1991
1991
Production of multimeric forms of CD4 through a sugar-based cross-linking strategy.
Ling-Ling Chen
,
Joseph J. Rosa
,
Sarah Turner
,
R. Pepinsky
Journal of Biological Chemistry
1991
Corpus ID: 41345930
1975
1975
MODIFICATION OF THE RAT ALLOIMMUNE RESPONSE BY ENHANCING ANTIBODIES AND THE ROLE OF BLOCKING FACTORS IN THE SURVIVAL OF RENAL GRAFTS
T. Strom
,
C. Carpenter
,
+4 authors
J. Soulillou
Transplantation
1975
Corpus ID: 20256939
Correlation of morphological and immunological events occurring in control and passively enhanced rat renal allograft recipients…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE